Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors(475 views) Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, Cremonesi M, Botta F, Nappi A, Improta G, Storto G, Benassi M, Orecchia R
Theor Biol Med Model (ISSN: 1742-4682), 2012 Jun 19; 9(1): 23-23.
I.R.C.C.S., C.R.O.B Regional Cancer Hospital, Rionero in Vulture, Italy
U.O. of Radiotherapy, I.E.O. European Institute of Oncology, Milan, Italy
University of Milan, Milan, Italy
Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute, Rome, Italy
U.O. of Radiobiology, C.N.A.O, Pavia, Italy
Service of Medical Physics, I.E.O. European Institute of Oncology, Milan, Italy
Department of Radiation Oncology, IRCCS CROB, 1 Padre Pio Street, 85028, Rionero in Vulture, PZ, Italy
I. R. C. C. S., C. R. O. B Regional Cancer Hospital, Rionero in Vulture, Italy
U. O. of Radiotherapy, I. E. O. European Institute of Oncology, Milan, Italy
U. O. of Radiobiology, C. N. A. O, Pavia, Italy
References: Not available.
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors